Hill Stephen A (CIK 0001237404)

Latest company ownership

Shares held
50,000
Last filed at
Jun 25, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q3 2025Q4
LPCN - Lipocine Inc.
Role: Director
Shares held
7,500
Last filed at
Dec 17, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q4 2025Q4
Shares held
1,190
Last filed at
Sep 6, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2013Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 4, 2020 Jun 8, 2020 Cellectar Biosciences, Inc. Director Buy 91.3 +18,000 100.00% ✗ $19.4K
Nov 29, 2018 Nov 30, 2018 Cellectar Biosciences, Inc. Director Sell 27.5 -992 -100.00% ✗ $2.2K
Sep 6, 2018 Sep 6, 2018 GYRE THERAPEUTICS, INC. Director Sell 27.5 -190 -13.77% ✗ $1.9K
Dec 29, 2017 Jan 2, 2018 Lipocine Inc. Director Sell 25.0 -1,250 -19.23% ✓ $4.3K
Apr 20, 2016 Apr 21, 2016 Cellectar Biosciences, Inc. Director Buy 91.3 +9,390 1771.70% ✗ $19.9K
Dec 17, 2015 Dec 18, 2015 GYRE THERAPEUTICS, INC. Director Buy 91.3 +5,000 31.82% ✗ $10.2K
Aug 28, 2015 Aug 31, 2015 GYRE THERAPEUTICS, INC. Director Sell 22.5 -12,146 -43.60% ✗ $81.6K
Nov 13, 2014 Nov 13, 2014 Lipocine Inc. Director Buy 91.3 +4,000 100.00% ✗ $19.8K
Aug 20, 2014 Aug 22, 2014 Cellectar Biosciences, Inc. Director Buy 91.3 +5,300 100.00% ✗ $19.9K
Mar 8, 2013 Mar 11, 2013 GYRE THERAPEUTICS, INC. CEO Buy 95.0 +20,000 100.00% ✗ $88.6K
Mar 8, 2013 Mar 11, 2013 GYRE THERAPEUTICS, INC. CEO Buy 95.0 +20,000 100.00% ✗ $88.6K